• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Autoimmune Immunoassay Brief

$3,000.00 – $6,000.00

Clear
SKU: 21-033 Category: Diagnostics Market Research Tags: ANCA, autoimmune diagnostic testing products, autoimmune diseases, autoimmune immunoassay, automated effective testing, celiac disease, cell and gene therapy, COVID-19, diabetes, IBS, inflammatory bowl disease, lupus, multiple sclerosis, myasthenia gravis, rheumatoid, Sjogren's syndrome, Telehealth, thyroid disease Pages: 66
  • Description
  • Table of Contents
  • Latest reports

Description

A considerable number of diagnostic tests are available or in development for the detection of autoimmune diseases. Because of this potentially large and growing market, vast opportunity exists for discovery and advancement in this arena. Competition within this market is expected to increase dramatically. However, in fledgling autoimmune IVD diagnostic testing markets, a golden opportunity exists to capitalize on new testing innovations without significant competition.

In terms of test options, a substantial amount of overlap exists in the various autoimmune tests available. With the continued medical discovery of autoimmune conditions, the research and development of accurate tests to identify specific diseases provide the potential revenue opportunities that may exist for future tests and competitors.

Scope and Methodology

Autoimmune Immunoassay Brief from Kalorama Information offers a geographic scope that is worldwide with information for specific geographical regions, world autoimmune demographics, and other general issues affecting the market. The market summary includes total market values, market analysis by region and test segment. Additionally, key company profiles are included.  The market does not include services for autoimmune immunoassay testing.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For the purpose of this study, Kalorama Information conducted interviews with over 12 industry officials, consultants, health care providers, and government personnel.  These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report.  Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests excluding services.  The base year for data was 2021. Compound annual growth rates (CAGRs) are provided for 2021-2026 periods. The forecasted market analysis for 2021-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.

 

Table of Contents

CHAPTER 1. EXECUTIVE SUMMARY

  • INTRODUCTION
  • SCOPE AND METHODOLOGY
  • SIZE AND GROWTH OF THE MARKET
      • Table 1-1: Autoimmune Immunoassay Market Analysis 2021-2026($ millions)
  • KEY ISSUES AND TRENDS AFFECTING THE MARKET
  • COMPETITIVE OUTLOOK
  • CONCLUSION HIGHLIGHTS
    • Conclusion 1: There are vast opportunities for manufacturers of autoimmune diagnostic testing products in the autoimmune arena
    • Conclusion 2: Women are disproportionately affected by autoimmune disease
    • Conclusion 3: Testing needs to be cost effective but precise to identify autoimmune diseases
    • Conclusion 4: Sophistication in testing is leading to more automated effective testing
    • Conclusion 5: Proteonomic research is furthering the discovery of autoimmune disease markers

CHAPTER 2: INTRODUCTION AND OVERVIEW

  • AUTOIMMUNITY
  • TYPES OF AUTOIMMUNE DISEASES
    • Rheumatoid Arthritis
    • Autoimmune Gastrointestinal Disease
      • Celiac Disease
      • Inflammatory bowel disease
  • SYSTEMIC LUPUS ERYTHEMATOSUS
  • AUTOIMMUNE THYROID DISEASE
  • MULTIPLE SCLEROSIS
  • SJOGREN’S SYNDROME
  • MYASTHENIA GRAVIS
  • TYPE 1 DIABETES
  • AUTOIMMUNE TESTING
    • Types of Tests
    • Anti-nuclear Antibody
    • Enzyme-linked Immunosorbent Assay
    • Rheumatoid Factor
    • ESR/CRP
    • IFA/ Anti-neutrophil Cytoplasmic Antibodies (ANCA)
  • PREVALENCE AND DEMOGRAPHICS OF AUTOIMMUNE DISEASE
      • Table 2-1: Prevalence of Selected Autoimmune Diseases 2020
      • (per 100,000 population est)
  • Prevalence in Women
      • Table 2-2: Male to Female Ratio of Autoimmune Disease 2020

CHAPTER 3: EMERGING TRENDS

  • COVID-19
  • PATIENT ENGAGEMENT/PATIENT-CENTERED HEALTHCARE
  • TELEHEALTH
  • INNOVATING POC
      • Table 3-1: Selected POC Test Innovations
      • Table 3-2: Selected POC Immunoassay Test Platforms
  • AUTOMATED AUTOIMMUNE DIAGNOSTIC PLATFORMS
  • CELL AND GENE THERAPY OPPORTUNITIES

CHAPTER 4: MARKET PARTICIPANTS

  • AESKU. DIAGNOSTICS GMBH & CO KG
      • Table 4-1: AESKU Corporate Summary
    • Company Overview
  • BINDING SITE GROUP LTD. (THE)
      • Table 4-2: Binding Site Corporate Summary
    • Company Overview
  • BIOMERICA, INC.
      • Table 4-3: Biomerica Corporate Summary
    • Company Overview
      • Table 4-4: Biomerica Corporation Revenue (2017-2020) ($ millions)
  • BIO-RAD LABORATORIES INC.
      • Table 4-5: Bio-Rad Labs Corporate Summary
    • Company Overview
      • Table 4-6: Bio-Rad Corporation Revenue (2017-2020) ($ millions)
  • DIASORIN, INC.
      • Table 4-7: DiaSorin Corporate Summary
    • Company Overview
      • Table 4-6: DiaSorin Corporation Revenue (2017-2020) ($ millions)
  • EUROIMMUN AG
      • Table 4-7: EUROIMMUN Corporate Summary
    • Company Overview
  • HOB BIOTECH GROUP
      • Table 4-8: HOB Biotech Corporate Summary
    • Company Overview
  • INOVA DIAGNOSTICS, INC.
      • Table 4-9: INOVA Diagnostics Corporate Summary
    • Company Overview
  • ORGENTEC DIAGNOSTIKA
      • Table 4-10: ORGENTEC Corporate Summary
    • Company Overview
  • ROCHE DIAGNOSTIC CORPORATION
      • Table 4-11: Roche Diagnostic Corporate Summary
    • Company Overview
      • Table 4-12: Roche Diagnostics (2017-2020) ($ millions)
  • SIEMENS HEALTHINEERS GMBH
      • Table 4-13: Siemens Healthineers Corporate Summary
    • Company Overview
      • Table 4-14: Siemens Healthineers (2017-2020) ($ millions)
  • THERADIG
      • Table 4-15: Theradig Corporate Summary
    • Company Overview
  • THERMO FISHER SCIENTIFIC
      • Table 4-16: Thermo Fisher Corporate Summary
    • Company Overview
      • Table 4-17: Thermo Fisher Corporation Revenue (2017-2020) ($ millions)
  • TOSOH BIOSCIENCE
      • Table 4-18: Tosoh Bioscience Corporate Summary
    • Company Overview
  • TRINITY BIOTECH PLC.
      • Table 4-19: Trinity Biotech Corporate Summary
    • Company Overview
      • Table 4-20: Trinity Biotech Revenue (2017-2020) ($ millions)
  • WERFEN
      • Table 4-21: Werfen Corporate Summary
    • Company Overview
      • Table 4-22: Werfen Corporation Revenue (2017-2020) ($ millions)
  • ZEUS SCIENTIFIC
      • Table 4-23: ZEUS Scientific Corporate Summary
    • Company Overview

CHAPTER 5: MARKET ANALYSIS

  • MARKET OVERVIEW
      • Table 5-1: Autoimmune Immunoassay Market Analysis 2021-2026($ millions)
  • MARKET BY REGION
    • Autoimmune Immunoassay Testing Market by Region
      • Table 5-2: Autoimmune Immunoassay Market by Region 2021
      • Table 5-3: Autoimmune Immunoassay Market by European Country, 2021
      • Table 5-4: Autoimmune Immunoassay Market by Rest of World Countries, 2021
  • MARKET BY SEGMENT
      • Table 5-5: Autoimmune Immunoassay Market Revenues by Segment Type, 2021 (in $millions)
      • Table 5-6: Autoimmune Immunoassay Market Segment Type by Percent, 2021
  • AUTOIMMUNE IMMUNOASSAY MARKET BY DISEASE TYPE
      • Figure 5-1: Autoimmune Immunoassay Market by Disease Type % 2021
  • COMPETITIVE ANALYSIS
    • INOVA
    • Thermo Fisher
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

    $3,000.00 – $6,000.00
  • Placeholder image

    Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical Applications

    $2,995.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Clinical Diagnostics MasterFileIn Vitro Diagnostics (IVD) Market in China, 2021
Scroll to top